Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence

Abstract

Over the past 5years both media and scientific interest has surged regarding the disorder myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS), not least because of the clinically similar manifestation in long COVID or post-COVID. In this review we discuss the process of clinical diagnosis and randomized controlled therapeutic studies on ME/CFS, and the similarities or differences to long COVID and post-COVID. So far, neither clear pathophysiologically causal nor therapeutic evidence-based results on ME/CFS have been identified in the many years of scientific research. Given the evident psychiatric comorbidity rates in patients with adiagnosis of ME/CFS, apsychosomatic etiology of this syndrome should be considered. Furthermore, aprecise and reliable diagnostic classification based on stricter criteria would benefit both pathophysiological and therapeutic research.